Site-specific assessment of spinal radiographic progression improves detection of TNF blocker-associated disease modification in axial spondyloarthritis: longitudinal observational data from the Swiss Clinical Quality Management Registry

Machado P, Landewé R, Braun J, et al. A stratified model for health outcomes in ankylosing spondylitis. Ann Rheum Dis. 2011;70:1758–64.

Article  PubMed  Google Scholar 

Machado P, Landewé R, Braun J, et al. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann Rheum Dis. 2010;69:1465–70.

Article  PubMed  Google Scholar 

Van den Bosch F, De Keyser F, Mielants H, et al. Tumor necrosis factor-alpha blockade in ankylosing spondylitis: a potent but expensive anti-inflammatory treatment or true disease modification? Arthritis Res Ther. 2005;7:121–3.

Article  PubMed  PubMed Central  Google Scholar 

Boel A, Molto A, van der Heijde D, et al. Do patients with axial spondyloarthritis with radiographic sacroiliitis fulfil both the modified New York criteria and the ASAS axial spondyloarthritis criteria? Results from eight cohorts. Ann Rheum Dis. 2019;78:1545–9.

Article  PubMed  Google Scholar 

Sepriano A, Ramiro S, van der Heijde D, et al. Biological DMARDs and disease modification in axial spondyloarthritis: a review through the lens of causal inference. RMD Open. 2021;7: e001654.

Article  PubMed  PubMed Central  Google Scholar 

Resnick D, Dwosh IL, Goergen TG, et al. Clinical and radiographic abnormalities in ankylosing spondylitis: a comparison of men and women. Radiology. 1976;119:293–7.

Article  CAS  PubMed  Google Scholar 

Brophy S, Mackay K, Al-Saidi A, et al. The natural history of ankylosing spondylitis as defined by radiological progression. J Rheumatol. 2002;29:1236–43.

PubMed  Google Scholar 

Hebeisen M, Micheroli R, Scherer A, et al. Spinal radiographic progression in axial spondyloarthritis and the impact of classification as nonradiographic versus radiographic disease: Data from the Swiss Clinical Quality Management cohort. PLoS ONE. 2020;15: e0230268.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gran JT, Skomsvoll JF. The outcome of ankylosing spondylitis: a study of 100 patients. Br J Rheumatol. 1997;36:766–71.

Article  CAS  PubMed  Google Scholar 

Jang JH, Ward MM, Rucker AN, et al. Ankylosing spondylitis: patterns of radiographic involvement – a re-examination of accepted principles in a cohort of 769 patients. Radiology. 2011;258:192–8.

Article  PubMed  PubMed Central  Google Scholar 

van Tubergen A, van der Heijde D, Dougados M, et al. Are syndesmophytes most prevalent in the lumbar or in the cervical spine in patients with ankylosing spondylitis and do they develop in a specific direction? Rheumatology (Oxford). 2012;51:1432–9.

Article  PubMed  Google Scholar 

Jacques P, Lambrecht S, Verheugen E, et al. Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells. Ann Rheum Dis. 2014;73:437–45.

Article  PubMed  Google Scholar 

de Bruin F, ter Horst S, Bloem HL, et al. Prevalence of degenerative changes of the spine on magnetic resonance images and radiographs in patients aged 16–45 years with chronic back pain of short duration in the Spondyloarthritis Caught Early (SPACE) cohort. Rheumatology (Oxford). 2016;55:56–65.

Article  PubMed  Google Scholar 

de Bruin F, Treyvaud MO, Feydy A, et al. Prevalence of degenerative changes and overlap with spondyloarthritis-associated lesions in the spine of patients from the DESIR cohort. RMD Open. 2018;4: e000657.

Article  PubMed  PubMed Central  Google Scholar 

Molnar C, Scherer A, Baraliakos X, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63–9.

Article  CAS  PubMed  Google Scholar 

Rudwaleit M, van der Heijde D, Landewé R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 2009;2009;68:777–83.

van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–8.

Article  CAS  PubMed  Google Scholar 

Sieper J, Rudwaleit M, Baraliakos X, Brandt J, Braun J, Burgos-Vargas R, et al. The Assessment of SpondyloArthritis international Society (ASAS) handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009;6(Suppl 2):ii1-44.

Google Scholar 

Creemers MC, Franssen MJ, van’t Hof MA, et al. Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis. 2005;64:127–9.

Article  CAS  PubMed  Google Scholar 

Baraliakos X, Listing J, Buschmann J, et al. A comparison of new bone formation in patients with ankylosing spondylitis and patients with diffuse idiopathic skeletal hyperostosis: a retrospective cohort study over six years. Arthritis Rheum. 2012;64:1127–33.

Article  CAS  PubMed  Google Scholar 

Ramiro S, Stolwijk C, van Tubergen A, et al. Evolution of radiographic damage in ankylosing spondylitis: a 12 year prospective follow-up of the OASIS study. Ann Rheum Dis. 2015;74:52–9.

Article  PubMed  Google Scholar 

van der Heijde D, Braun J, Deodhar A, et al. Modified stoke ankylosing spondylitis spinal score as an outcome measure to assess the impact of treatment on structural progression in ankylosing spondylitis. Rheumatology (Oxford). 2019;58:388–400.

Article  PubMed  Google Scholar 

Wanders A, van der Heijde D, Landewé R, et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial. Arthritis Rheum. 2005;52:1756–65.

Article  CAS  PubMed  Google Scholar 

Sieper J, Listing J, Poddubnyy D, et al. Effect of continuous versus on-demand treatment of ankylosing spondylitis with diclofenac over 2 years on radiographic progression of the spine: results from a randomized multicenter trial (ENRADAS). Ann Rheum Dis. 2016;75:1438–43.

Article  CAS  PubMed  Google Scholar 

Machado PM, Baraliakos X, van der Heijde D, et al. MRI vertebral corner inflammation followed by fat deposition is the strongest contributor to the development of new bone at the same vertebral corner: a multilevel longitudinal analysis in patients with ankylosing spondylitis. Ann Rheum Dis. 2016;75:1486–93.

Article  PubMed  Google Scholar 

den Hollander W, Ramos YFM, Bos SD, et al. Knee and hip articular cartilage have distinct epigenomic landscapes: implications for future cartilage regeneration approaches. Ann Rheum Dis. 2014;73:2208–12.

Article  Google Scholar 

Frank-Bertoncelj M, Trenkmann M, Klein K, et al. Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions. Nat Commun. 2017;8:14852.27.

Article  Google Scholar 

Dougados M, Simon P, Braun J, et al. ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis. Ann Rheum. 2011;70:249–51.

Article  CAS  Google Scholar 

Park JW, Kim MJ, Lee JS, et al. Impact of tumor necrosis factor inhibitor versus nonsteroidal antiinflammatory drug treatment on radiographic progression in early ankylosing spondylitis: its relationship to inflammation control during treatment. Arthritis Rheumatol. 2019;71:82–90.

Article  CAS  PubMed  Google Scholar 

Ramiro S, Landewé R, van Tubergen A, et al. Lifestyle factors may modify the effect of disease activity on radiographic progression in patients with ankylosing spondylitis: a longitudinal analysis. RMD Open. 2015;1: e000153.

Article  PubMed  PubMed Central  Google Scholar 

Nikiphorou E, Ramiro S, Sepriano A, et al. Do smoking and socioeconomic factors influence imaging outcomes in axial spondyloarthritis? Five-year data from the DESIR cohort. Arthritis Rheumatol. 2020;72:1855–62.

Article  PubMed  PubMed Central  Google Scholar 

Baraliakos X, Ostergaard M, Poddubnyy D, et al. Effect of secukinumab versus adalimumab biosimilar on radiographic progression in patients with radiographic axial spondyloarthritis: a randomized phase IIIb study (abstract). Arthritis Rheumatol. 2022;74(suppl 9). https://acrabstracts.org/abstract/effect-of-secukinumab-versus-adalimumab-biosimilar-on-radiographic-progression-in-patients-with-radiographic-axial-spondyloarthritis-a-randomized-phase-iiib-study/. Accessed 9 Mar 2023.

留言 (0)

沒有登入
gif